Thiazolyl Blue
Names
[ CAS No. ]:
298-93-1
[ Name ]:
Thiazolyl Blue
[Synonym ]:
3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyltetrazolium Bromide
ThiazolylBlue(Mtt)
MttA.R.
2H-Tetrazolium, 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-, bromide (1:1)
3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium Bromide
3-(4,5-Dimethyl-1,3-thiazol-2-yl)-2,5-diphenyl-2H-tetrazol-3-ium bromide
Methylthiazoletetrazolium bromide
Thiazolyl Blue
2H-tetrazolium, 2-(4,5-dimethyl-2-thiazolyl)-3,5-diphenyl-, bromide (1:1)
2-(4,5-Dimethyl-1,3-thiazol-2-yl)-3,5-diphenyl-2H-tetrazol-3-ium bromide
MFCD00011964
EINECS 206-069-5
THIAZOLE BLUE
Thiazolyl blue tetrazolium bromide (MTT)
thiazolyl blue tetrazolium bromide
mmttetrazolium
3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyl-2H-Tetrazolium Bromide
MTT
Biological Activity
[Description]:
[Related Catalog]:
[In Vitro]
[References]
[Related Small Molecules]
Chemical & Physical Properties
[ Melting Point ]:
195 °C (dec.)(lit.)
[ Molecular Formula ]:
C18H16BrN5S
[ Molecular Weight ]:
414.322
[ Exact Mass ]:
413.030975
[ PSA ]:
75.72000
[ LogP ]:
0.28830
[ Storage condition ]:
2-8°C
[ Water Solubility ]:
Slightly soluble
MSDS
Toxicological Information
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- XF8060000
- CHEMICAL NAME :
- 2H-Tetrazolium, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-, bromide
- CAS REGISTRY NUMBER :
- 298-93-1
- LAST UPDATED :
- 199701
- DATA ITEMS CITED :
- 4
- MOLECULAR FORMULA :
- C18-H16-N5-S.Br
- MOLECULAR WEIGHT :
- 414.36
- WISWESSER LINE NOTATION :
- T5NNKNJ BR& ER& C- BT5N CSJ D1 E1 &E
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
MUTATION DATA
- TYPE OF TEST :
- Mutation in microorganisms
- TEST SYSTEM :
- Bacteria - Escherichia coli
- DOSE/DURATION :
- 5 ug/plate
- REFERENCE :
- MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 68,107,1979 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X1328 No. of Facilities: 93 (estimated) No. of Industries: 1 No. of Occupations: 3 No. of Employees: 1106 (estimated) No. of Female Employees: 985 (estimated)
Safety Information
[ Symbol ]:
GHS07, GHS08
[ Signal Word ]:
Warning
[ Hazard Statements ]:
H315-H319-H335-H341
[ Precautionary Statements ]:
P261-P281-P305 + P351 + P338
[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
[ Hazard Codes ]:
Xi: Irritant;
[ Risk Phrases ]:
R46
[ Safety Phrases ]:
S22-S24/25
[ RIDADR ]:
NONH for all modes of transport
[ WGK Germany ]:
3
[ RTECS ]:
XF8060000
[ HS Code ]:
29341000
Customs
[ HS Code ]: 29341000
Articles
J. Ethnopharmacol. 159 , 93-101, (2014)
Previous studies in our laboratory revealed the neuroprotective effect of modified Yeoldahanso-tang (MYH) in models of Parkinson׳s disease (PD). In this study, we investigated another traditional Kore...
Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.Drug Des. Devel. Ther. 9 , 1555-84, (2015)
Osteosarcoma (OS) is the most common malignant bone tumor occurring mostly in children and adolescents between 10 and 20 years of age with poor response to current therapeutics. Alisertib (ALS, MLN823...
Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cells.Drug Des. Devel. Ther. 9 , 425-64, (2015)
Ovarian cancer is a leading killer of women, and no cure for advanced ovarian cancer is available. Alisertib (ALS), a selective Aurora kinase A (AURKA) inhibitor, has shown potent anticancer effects, ...